Mindzilla – Coronavirus

Coronavirus

COVID-19 Studies should also Focus on Mucosal Immunity, Researchers Argue

November 30, 2020
Mindzilla

Buffalo, NY — Anyone who has undergone a nasal swab or saliva test for COVID-19 knows that the virus is most easily detected in the nose and mouth. That’s why, University at Buffalo researchers...

Immune Strategy Based on Limited Information in the Network

November 27, 2020
Mindzilla

Changsha, China — The novel coronavirus outbreak is a global pandemic that has spread to more than 200 countries and territories around the world. Currently, countries and territories are fighting...

Drug Aprotinin Inhibits Entry of SARS-CoV2 in Host Cells

November 24, 2020
Mindzilla

Frankfurt, Germany — The surface of the SARS-CoV-2 virus is studded with spike proteins. The virus needs these in order to dock onto proteins (ACE2 receptors) on the surface of the host cell. Before...

A Sulfur Molecule to Block the Coronavirus

November 23, 2020
Mindzilla

Geneva, Switzerland — The cell membrane is impermeable to viruses: to get inside and infect a cell, they use a range of strategies to exploit the cellular and biochemical properties of the membranes....

Adipose Tissue may be the Source of Inflammatory Factors that Aggravate COVID-19

November 23, 2020
Mindzilla

São Paulo, Brazil — There is growing evidence that adipose tissue plays a key role in the aggravation of COVID-19. One of the theories under investigation is that fat cells (adipocytes) act as a reservoir...

Folding of SARS-CoV2 genome reveals drug targets — and preparation for ‘SARS-CoV3’

November 23, 2020
Mindzilla

Frankfurt, Germany — The genetic code of the SARS-CoV2 virus is exactly 29,902 characters long, strung through a long RNA molecule. It contains the information for the production of 27 proteins. This...

Insights on a Mechanism to Stop COVID-19 Replication

November 20, 2020
Mindzilla

Milan, Italy — Stopping the replication of SARS-CoV-2 is likely possible thanks to a compound called EBSELEN: a group of researchers from the Politecnico di Milano has communicated aspects relevant...

Antibody Cocktails at Low Doses could be More Effective at Treating COVID-19

November 20, 2020
Mindzilla

New York, NY — Pairs of antibodies may be more effective than single antibodies at preventing and treating COVID-19, according to a new study by researchers at the University of North Carolina at Chapel...

Vibrations of Coronavirus Proteins may Play a Role in Infection

November 20, 2020
Mindzilla

Cambridge, MA — When someone struggles to open a lock with a key that doesn’t quite seem to work, sometimes jiggling the key a bit will help. Now, new research from MIT suggests that coronaviruses,...

Study reveals how smoking worsens COVID-19 infection in the airways

November 19, 2020
Helen Yiu

Los Angeles, CA — UCLA researchers using a model of airway tissue created from human stem cells have pinpointed how smoking cigarettes causes more severe infection by SARS-CoV-2, the virus that causes...

Comprehensive Safety Testing of COVID-19 Vaccines Based on Experience with Prior Vaccines

November 19, 2020
Mindzilla

Washington, DC — “The urgent need for COVID-19 vaccines must be balanced with the imperative of ensuring safety and public confidence in vaccines by following the established clinical safety...

Kids Mount a COVID-19 Immune Response without Detection of SARSCoV- 2 virus

November 19, 2020
Mindzilla

Victoria, Australia — Children in a Melbourne family developed a COVID-19 immune response after chronic exposure to the SARS-CoV-2 virus from their parents, a new case report has found. The research,...

Dissecting the Immune Characteristics of Severe COVID-19 Responses

November 16, 2020
Mindzilla

Cambridge, UK — A team of immunology experts from research organisations in Belgium and the UK have come together to apply their pioneering research methods to put individuals’ COVID-19 response...

Two Anti-Inflammatory Compounds Shown to be Capable of Accelerating Recovery from COVID-19

November 16, 2020
Mindzilla

São Paulo, Brazil — Two independent clinical studies – one by researchers at the Center for Cell-Based Therapy (CTC) in Ribeirão Preto, state of São Paulo (Brazil), on the monoclonal antibody eculizumab,...

Researchers Identify Promising New Compounds to Potentially Treat Novel Coronaviruses

November 16, 2020
Mindzilla

Baltimore, MD — Researchers at the University of Maryland School of Medicine (UMSOM) and School of Pharmacy (UMSOP) have discovered new drug compounds to potentially treat the novel coronavirus that...

Examining Impact of a Point Mutation in SARS-Cov-2 Spike on Virus Transmission and Pathogenicity

November 13, 2020
Mindzilla

Washington, DC — The current dominant variant of SARS-CoV-2, containing a D614G substitution in the spike protein, appears to have evolved to enhance transmissibility, according to a new study in human...

Peering Under the “Hood” of SARS-CoV-2

November 9, 2020
Mindzilla

Thuwal, Saudi Arabia — Information from electron microscope images and protein databases has been used to develop a detailed 3D model of SARS-CoV-2, which can be readily updated as new data becomes...

Study Reveals Strategy to Create COVID-19 Drugs to Inhibit Virus’s Entry and Replication

November 6, 2020
Mindzilla

Tampa FL — SARS-CoV-2, the respiratory virus that causes COVID-19, attacks the body in multiple steps. Gaining entry into cells deep within the lungs and hijacking the human host cell’s machinery...

Scientists Identify Synthetic Mini-Antibody to Combat COVID-19

November 5, 2020
Mindzilla

Heidelberg, Germany — The ability of SARS-CoV-2 to infect cells depends on interactions between the viral spike protein and the human cell surface protein ACE2. To enable the virus to hook onto the...

Study Uncovers Subset of COVID-19 Patients who Recover Quickly and Sustain Antibodies

November 4, 2020
Mindzilla

Boston, MA — One of the pressing questions about COVID-19 remains: How long does immunity last? One key indicator of immunity is the presence of virus-specific antibodies. Previous studies have provided...

T&C

Privacy